Table 1.
Patient characteristics at baseline in patients selected in the analysis and patients starting 3 or more cART in TAHOD
| In analysis | In TAHOD | In analysis | In TAHOD | ||
|---|---|---|---|---|---|
| Total patients | 1676 | 4056 | Haemoglobin (g/dL) at cART initiation | ||
| Age (year) at cART initiation | Median (IQR) | 14.0 (12.6, 15.2) | 12.3 (10.8, 14.2) | ||
| Median (IQR) | 36 (30, 42) | 35 (30, 41) | < 10 g/dL | 27 (2%) | 418 (16%) |
| <=30 | 437 (26%) | 1188 (29%) | 10+g/dL | 1248 (98%) | 2250 (84%) |
| 31~40 | 748 (45%) | 1814 (45%) | Not tested | 221 | 1388 |
| 41 or more | 491 (29%) | 1054 (26%) | CD4 count (cells/μL) at cART initiation | ||
| Median (IQR) | 140 (42, 230) | 112 (37, 209) | |||
| Gender | <=50 | 350 (28%) | 990 (31%) | ||
| Male | 1238 (74%) | 2875 (71%) | 51-100 | 155 (12%) | 508 (16%) |
| Female | 438 (26%) | 1177 (29%) | 101-200 | 328 (26%) | 815 (26%) |
| Transgender | 0 (0%) | 4 (< 1%) | 201-300 | 261 (21%) | 551 (17%) |
| 301 or more | 161 (13%) | 311 (10%) | |||
| CDC clinical classification for HIV infection at cART initiation | Not tested | 421 | 881 | ||
| Stage A | 980 (58%) | 1984 (50%) | HIV viral load (copies/ml) at cART initiation | ||
| Stage B | 101 (6%) | 407 (10%) | Median log10 (IQR) | 4.93 (4.22, 5.52) | 4.94 (4.32, 5.51) |
| Stage C | 595 (36%) | 1665 (41%) | < 500 | 101 (11%) | 126 (9%) |
| 501-10,000 | 80 (9%) | 124 (9%) | |||
| Hepatitis B or C coinfection | 10,001-50,000 | 173 (19%) | 280 (20%) | ||
| No | 1468 (88%) | 3495 (86%) | 50,001 or more | 555 (61%) | 885 (62%) |
| Yes | 208 (12%) | 566 (14%) | Not tested | 767 | 2641 |